Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-11-20 Arkowitz David Director Grant or award · Stock Option (right to buy) +13,500 13,500
2025-10-20 Duran Felipe Chief Financial Officer Grant or award · Stock Option (right to buy) +75,000 75,000
2025-10-20 Banjak Marc Chief Legal Officer Grant or award · Stock Option (right to buy) +55,000 55,000
2025-10-20 Brenner Martin See Remarks Grant or award · Stock Option (right to buy) +180,000 180,000
2025-02-21 Banjak Marc Chief Legal Officer Grant or award · Stock Option (right to buy) +71,000 71,000
2025-02-21 Duran Felipe Chief Financial Officer Grant or award · Stock Option (right to buy) +84,700 84,700
2025-02-21 Brenner Martin See Remarks Grant or award · Stock Option (right to buy) +230,700 230,700
2025-01-10 Duran Felipe Chief Financial Officer Purchase +9,191 $2.72 $25K 11,139
2025-01-10 Brenner Martin See Remarks Purchase +9,191 $2.72 $25K 18,316
2025-01-10 Banjak Marc Chief Legal Officer Purchase +9,191 $2.72 $25K 11,066
2025-01-10 Arkowitz David Director Purchase +18,382 $2.72 $50K 18,382
2025-01-10 Clark William D Director Purchase +1,838 $2.72 $5K 1,838
2025-01-10 Parada Antonio Bernardino Guimaraes Director Purchase +183,823 $2.72 $500K 183,823
2025-01-10 Sender Gary Director Purchase +9,191 $2.72 $25K 9,191
2024-11-21 Parada Antonio Bernardino Guimaraes Director Grant or award · Stock Option (right to buy) +12,600 12,600
2024-11-21 Sender Gary Director Grant or award · Stock Option (right to buy) +18,900 18,900
2024-11-21 Schimmelpennink Evert B. Director Grant or award · Stock Option (right to buy) +18,900 18,900
2024-11-21 Kropotova Alexandra Director Grant or award · Stock Option (right to buy) +18,900 18,900
2024-11-21 Clark William D Director Grant or award · Stock Option (right to buy) +18,900 18,900
2024-11-21 Arkowitz David Director Grant or award · Stock Option (right to buy) +12,600 12,600

Page 2 of 7 · 126 trades